Article Text

PDF
In vivo single-photon emission computed tomography imaging of apoptosis in Crohn’s disease and anti-tumour necrosis factor therapy
  1. Alastair J M Watson
  1. Correspondence to:
    Professor Alastair Watson
    School of Clinical Sciences, The Henry Wellcome Laboratory, Nuffield Building, University of Liverpool, Crown Street, Liverpool L69 3GE, UK; Alastair.watson{at}liv.ac.uk

Statistics from Altmetric.com

It has long been known that apoptosis of T cells is an important mechanism for terminating inflammatory reactions.1 It was proposed over 10 years ago that defective apoptosis could play a role in the pathogenesis of inflammatory bowel disease.2 There is now substantial experimental and clinical evidence supporting this hypothesis.3

In Crohn’s disease there is an expansion in CD4 T-cell populations mediated by tumour necrosis factor (TNF) and γ-interferon (IFN-γ), which activate macrophages to release interleukin-6, interleukin-12 and TNF.4,5 These cytokines act to perpetuate the inflammatory reaction by reducing the susceptibility of T cells to die by apoptosis.3 In the uninflammed state, lamina propria T cells have a higher susceptibility to apoptosis than unstimulated T cells from the peripheral blood because of high expression of the apoptosis-inducing receptor Fas.6 In contrast to this, lamina propria T cells from patients with Crohn’s disease are resistant to apoptotic stimuli.7 These observations suggest that apoptosis limits the number of CD4 T cells in healthy individuals whereas in Crohn’s disease expansion of T-cell populations can occur without the restriction of apoptosis.

This resistance to induction of apoptosis is mediated by interleukin-12, the interleukin-6 receptor and TNF. Interleukin-12 is one of the most important cytokines in Crohn’s disease promoting Th1 T-cell differentiation. It also renders T cells resistant to Fas-induced apoptosis, possibly through inhibition of caspase 3 and 9, thereby prolonging T-cell survival.8 Early clinical studies have shown that antibodies that block the action of interleukin-12 reduce the severity of Crohn’s disease.9 Such antibodies also increase apoptosis in lamina propria T cells and reduce the severity of trinitrobenzene sulphonic acid experimental colitis.5

Interleukin-6 secreted by lamina propria macrophages and T cells also promotes the survival of T cells by inhibiting …

View Full Text

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Linked Articles